Tools chosen: kalshi_direct claude_news congress_bills congress_bills kalshi_related polymarket_related wikipedia gdelt_news

Sub-questions (Fermi decomposition)

Planner reasoning

This is a long-horizon Kalshi question about whether a formal, congressionally-approved free trade agreement becomes law under Trump before Jan 2029. Key uncertainties are the distinction between recent 'trade deals/frameworks' (UK, Japan, EU announcements) and a true FTA requiring implementing legislation, whether Trade Promotion Authority exists, and the historical timeline for FTA negotiation-to-ratification. The market price is the anchor; news and legislative tracking will reveal whether any deal is on a path to Congressional approval.

# Current state Kalshi YES price is 39% and trending down (-8% in 7 days, -10% in 30 days), reflecting growing market skepticism that a formal, congressionally-implemented FTA will occur before Jan 20, 2029. The Trump administration has consistently pursued non-binding "framework agreements" and "Agreements on Reciprocal Trade" (ARTs) via executive action (IEEPA/Section 232), not FTAs requiring Congressional implementing legislation — the specific resolution criterion for this market. # Timeline of key events - 2021-07: TPA (fast-track authority) expires; not renewed under Biden or (as of 2026) Trump — confirmed (CRS). - 2025 (throughout): USTR signs ARTs with Argentina, Bangladesh, Cambodia, El Salvador, Guatemala, Indonesia, Malaysia, Taiwan — confirmed non-FTA instruments (USTR 2026 Trade Policy Agenda). - 2025-07: US-EU framework agreement announced on tariffs/trade — confirmed framework, not FTA (CRS IF13107). - 2025-09: EO 14345 implements provisions of US-Japan agreement via executive order — confirmed, no Congressional bill (CRS IN12608). - 2025 (various): UK, Switzerland/Liechtenstein "trade deals" concluded as frameworks, not FTAs — confirmed (CRS IN12645). - 2026-02: US-India "framework for an Interim Agreement" announced, with intent to later negotiate full Bilateral Trade Agreement — confirmed as preliminary step (White House fact sheet). - 2026-01-27: India–EU FTA concluded (comparison case) — shows what a full ratification-track FTA looks like; no US equivalent exists — confirmed (Wikipedia). - 2026-07-01: US declines to renew USMCA under mandatory review; parties move to annual review process instead — confirmed (Wikipedia), signals continued preference for non-FTA/renegotiation mechanisms over new comprehensive deals. - 2026-07 to 2026-08: Other countries (UAE-Canada CEPA, Bangladesh-EU) advance FTAs; no similar Congressional-track US FTA news — reported (GDELT). # Event Will a Trump-era free trade agreement (with formal Senate ratification or Congressional-Executive Agreement + implementing legislation) become law before Jan 20, 2029? # Outcomes to forecast Yes / No # Kalshi market anchor KXFTA-29 currently at **39% YES**, down from a 50% high; 7-day -8%, 30-day -10%; low volume (~28 contracts/day avg) over 33 days of data — thin but consistently declining market. # Sub-question answers 1. **Current Kalshi price/trend** — 39% YES, declining trend (-8%/7d, -10%/30d), range 38-50% [kalshi_direct]. 2. **Are announced deals (UK, Japan, EU, India) formal FTAs with implementing legislation?** — No. All are "framework agreements," "ARTs," or "interim agreements" implemented via executive order/proclamation (IEEPA, Section 232); none submitted to Congress as FTAs [CRS, USTR, White House]. 3. **TPA status** — Lapsed July 2021, not renewed; no indication Trump admin has requested renewal as of 2026 [CRS, Wikipedia]. 4. **Historical FTA timeline base rate** — USMCA took ~3 years (2017 launch to 2020 effect) under TPA; without TPA, timeline is longer/uncertain since normal Senate treaty (2/3) or CEA majority-vote process lacks fast-track protections. ~3 years remain until close, technically feasible but requires a policy pivot not currently evident. 5. **Pending FTA implementing bills in 119th Congress** — None found; keyword searches for "free trade agreement implementing legislation" and "trade promotion authority" returned no relevant bills [congress_bills]. 6. **Related prediction markets** — Kalshi KXFTAPRC-29 (China FTA) trades at 19% (down from 40% high); Polymarket has no matching markets. No cross-market bullish signal [kalshi_related, polymarket_related]. # Key facts (high-confidence, factual) 1. [CRS/USTR] Trump admin explicitly favors frameworks/ARTs over FTAs; 2026 Trade Policy Agenda states FTAs "will not solve structural economic imbalances." 2. [Wikipedia] TPA lapsed 2021, unrenewed under both Biden and Trump. 3. [Wikipedia] US declined USMCA renewal in July 2026, opting for annual review instead of new comprehensive deal. 4. [congress_bills] No FTA-implementing or TPA-renewal bills active in 119th Congress per search. 5. [kalshi_related] Sister market (China FTA) at 19%, also declining — consistent skepticism across trade-FTA markets. # Cross-market signals - Kalshi related: KXFTAPRC-29 (China FTA) at 19%, down 10% in 30 days — same downward trend. - Polymarket: No matching markets found; no signal. - Sportsbook implied: N/A (not applicable to policy market). # Analyst opinions and speculation - Trade law analysts (Chambers) expect the "framework agreement" trend to continue rather than reverse toward binding FTAs. - Commentary (Globe and Mail, Epoch Times) frames Trump-era deals as transactional/tariff-focused rather than comprehensive trade liberalization, reinforcing the framework-not-FTA pattern. # Directional lean per outcome - **Yes**: ~3 years remain; India BTA/broader deal talks ongoing; possible pivot if Congress reasserts role or a partner insists on binding treaty. Weak/speculative support only. - **No**: Structural evidence dominant — no TPA, explicit USTR strategy against FTAs, no bills in Congress, consistent framework/ART pattern across 10+ deals, USMCA non-renewal. Strong support. # Gaps / unknowns - Whether India's eventual "BTA" could evolve into formal implementing legislation before 2029 — timeline unclear. - No visibility into any confidential negotiations that could shift toward binding treaty status. - Kalshi's declining price may already reflect most of this evidence; unclear if further downside is warranted. # Calibration anchors - Kalshi YES price: 39% (anchor), trending down. - Sister market (China FTA): 19%, also trending down — suggests market-wide skepticism on any formal Trump FTA. - Historical precedent: Under TPA, USMCA took ~3 years negotiation-to-force; without TPA, no comparable full FTA has been completed by any administration since 2021.

1. Both forecasts land in a narrow 28-31% band despite one being anchored at 0.62 confidence and the other at 0.68 — there's essentially no diagnostic disagreement between them, and neither explains why they discount from Kalshi's 39% by only 8-11 points when the brief's "No" case is described as "structural" and "dominant" (no TPA, no bills, explicit anti-FTA USTR agenda, USMCA non-renewal) versus a "weak/speculative" Yes case. 2. Neither forecaster reconciles the relationship between this "any country" market (39%) and the sister "China FTA" market (19%) — if China is the hardest single case, the "any country" price being only ~2x the China price implies the market sees little independent probability mass in other bilateral tracks (UK, EU, Japan, India), which should either push the "any country" estimate higher (more shots on goal) or reveal that Kalshi's 39% is stale/mispriced relative to the harder structural evidence; the forecasts don't address this discrepancy explicitly. 3. Both treat India's BTA as the primary Yes pathway but never decompose it probabilistically (e.g., P(interim framework upgrades to full BTA) × P(Congress passes implementing legislation by 2029)); given the brief notes "framework for an Interim Agreement" as merely a "preliminary step" with no timeline, this pathway is likely overweighted in both forecasts' qualitative reasoning relative to its evidentiary thinness. 4. Neither considers a tail scenario where an FTA-like implementing provision gets attached as a rider to an omnibus/appropriations bill or a renegotiated USMCA successor is later reclassified as a CEA with implementing legislation — a plausible political mechanism given precedent (USMCA itself was a CEA) that isn't discussed as a distinct Yes pathway. 5. Neither forecast explicitly extrapolates the Kalshi trend forward — given -8%/7d and -10%/30d with ~3 years remaining and no evident catalyst for reversal, a continuation of trend alone might justify pricing closer to the China-FTA market's 19% rather than converging near 28-31%, suggesting both may be anchoring too heavily on the current Kalshi snapshot rather than its trajectory. 6. The low volume/thin market caveat (~28 contracts/day) is mentioned in the brief but neither forecaster discusses how much weight to place on Kalshi's price given potential noise — both use it as a firm anchor without adjusting for its stated unreliability.

25% (65% confidence)

Yes: 25% No: 75%

The structural case for No is unusually strong and specific: TPA lapsed with no renewal request, USTR's 2026 agenda explicitly rejects FTAs, all 10+ Trump-era deals are executive-action frameworks, no implementing bills exist in Congress, and USMCA was allowed to lapse into annual review. The critique correctly notes both forecasters anchored too heavily on Kalshi's thin, declining 39% snapshot rather than the evidence trajectory — the sister China-FTA market at 19% and the consistent downtrend suggest the market itself is still adjusting downward. I move slightly below both forecasts to 25% YES, but not further, because ~3 years remain, the India BTA pathway exists (however preliminary), and tail mechanisms like a rider-attached CEA or reclassified USMCA successor preserve genuine Yes probability that shouldn't be dismissed on a 3-year horizon.

Total pipeline time: 156.0s